Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double-Blind Placebo-Controlled Phase 3 Clinical Studies

Messoud Ashina; Raghavendra Vasudeva; Leah Jin; Louise Lombard; Elizabeth Gray; Erin G. Doty; Laura Yunes-Medina; Kraig S. Kinchen; Cristina Tassorelli

doi:10.1111/head.13636

Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double-Blind Placebo-Controlled Phase 3 Clinical Studies

Messoud Ashina, Raghavendra Vasudeva, Leah Jin, Louise Lombard, Elizabeth Gray, Erin G. Doty, Laura Yunes-Medina, Kraig S. Kinchen, Cristina Tassorelli

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

31 Citationer (Scopus)

67 Downloads (Pure)

Originalsprog	Engelsk
Tidsskrift	Headache
Vol/bind	59
Udgave nummer	10
Sider (fra-til)	1788-1801
ISSN	0017-8748
DOI	https://doi.org/10.1111/head.13636
Status	Udgivet - 2019

Adgang til dokumentet

10.1111/head.13636Licens: CC BY-NC-ND

Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double-Blind Placebo-Controlled Phase 3 Clinical StudiesForlagets udgivne version, 696 KBLicens: CC BY-NC-ND

Citationsformater

Ashina, M., Vasudeva, R., Jin, L., Lombard, L., Gray, E., Doty, E. G., Yunes-Medina, L., Kinchen, K. S., & Tassorelli, C. (2019). Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double-Blind Placebo-Controlled Phase 3 Clinical Studies. Headache, 59(10), 1788-1801. https://doi.org/10.1111/head.13636

Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double-Blind Placebo-Controlled Phase 3 Clinical Studies. / Ashina, Messoud; Vasudeva, Raghavendra; Jin, Leah et al.
I: Headache, Bind 59, Nr. 10, 2019, s. 1788-1801.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Ashina, M, Vasudeva, R, Jin, L, Lombard, L, Gray, E, Doty, EG, Yunes-Medina, L, Kinchen, KS & Tassorelli, C 2019, 'Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double-Blind Placebo-Controlled Phase 3 Clinical Studies', Headache, bind 59, nr. 10, s. 1788-1801. https://doi.org/10.1111/head.13636

@article{f9b6afaa5917427aad0507bc8aaa7f73,

title = "Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double-Blind Placebo-Controlled Phase 3 Clinical Studies",

keywords = "lasmiditan, migraine, onset of efficacy, onset of response, acute treatment, ditan class",

author = "Messoud Ashina and Raghavendra Vasudeva and Leah Jin and Louise Lombard and Elizabeth Gray and Doty, {Erin G.} and Laura Yunes-Medina and Kinchen, {Kraig S.} and Cristina Tassorelli",

year = "2019",

doi = "10.1111/head.13636",

language = "English",

volume = "59",

pages = "1788--1801",

journal = "Headache",

issn = "0017-8748",

publisher = "Wiley-Blackwell",

number = "10",

}

TY - JOUR

T1 - Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine

T2 - Integrated Results From 2 Randomized Double-Blind Placebo-Controlled Phase 3 Clinical Studies

AU - Ashina, Messoud

AU - Vasudeva, Raghavendra

AU - Jin, Leah

AU - Lombard, Louise

AU - Gray, Elizabeth

AU - Doty, Erin G.

AU - Yunes-Medina, Laura

AU - Kinchen, Kraig S.

AU - Tassorelli, Cristina

PY - 2019

Y1 - 2019

KW - lasmiditan

KW - migraine

KW - onset of efficacy

KW - onset of response

KW - acute treatment

KW - ditan class

U2 - 10.1111/head.13636

DO - 10.1111/head.13636

M3 - Journal article

C2 - 31529622

SN - 0017-8748

VL - 59

SP - 1788

EP - 1801

JO - Headache

JF - Headache

IS - 10

ER -